HealthCare am MIT
von 
Big strides in cancer detection and treatment from the tiniest technologiesvon 
Elazer Edelman receives the 2026-2027 Killian Awardvon 
A new approach to cancer vaccination yields more powerful T cellsvon
A new approach to cancer vaccination yields more powerful T cellsvon 
MIT School of Engineering faculty receive awards in winter 2026von 
Celebrating dorm-to-market social entrepreneurship at MITvon 
MIT BrainTrust supports neighbors living with brain injuriesvon 
Beacon Biosignals is mapping the brain during sleepvon 
Study: Immigrants help address the US eldercare shortagevon 
Mapping molecular markers of physical fitnessvon 
Self-organizing “pencil beam” laser could help scientists design brain-targeted therapiesvon 
New chip can protect wireless biomedical devices from quantum attacksvon 
Two MIT alumnae named 2026 Gates Cambridge Scholarsvon 
Youth may increase vulnerability to a carcinogen found in contaminated water and some drugsvon 
MIT study reveals a new role for cell membranesvon 
Sixteen new START.nano companies are developing hard-tech solutions with the support of MIT.nanovon 
How bacteria suppress immune defenses in stubborn wound infectionsvon 
Turning muscles into motors gives static organs new lifevon 
MIT engineers design proteins by their motion, not just their shapevon 
Study reveals why some cancer therapies don’t work for all patientsvon
Study reveals why some cancer therapies don’t work for all patientsvon 
Implantable islet cells could control diabetes without insulin injectionsvon 
Enduring passions for medicine, journalism, and triathlonsvon
Enduring passions for medicine, journalism, and triathlonsvon 
How to create “humble” AIvon 
Bridging medical realities in the study of technology and healthvon 
After 16 years leading Picower Institute, Li-Huei Tsai will sharpen focus on research, teachingvon 
Improving cartilage repair through cell therapyvon 
Pursuing a passion for public healthvon 
New sensor sniffs out pneumonia on a patient’s breathvon 
Scientists discover genetics behind leaky brain blood vessels in Rett syndromevon 
3 Questions: Building predictive models to characterize tumor progressionvon 
Personal tech, social media, and the “decline of humanity”von 
Injectable “satellite livers” could offer an alternative to liver transplantationvon 
W.M. Keck Foundation to support research on healthy aging at MITvon 
AI to help researchers see the bigger picture in cell biologyvon 
A portable ultrasound sensor may enable earlier detection of breast cancervon 
Cancer’s secret safety netvon 
Richard Hynes, a pioneer in the biology of cellular adhesion, dies at 81von 
AI-generated sensors open new paths for early cancer detectionvon 
Study: High-fat diets make liver cells more likely to become cancerousvon 
A new immunotherapy approach could work for many types of cancervon 
MIT researchers find new immunotherapeutic targets for glioblastomavon 
A new way to deliver antibodies could make treatment much easier for patientsvon 
Prognostic tool could help clinicians identify high-risk cancer patientsvon 
MIT chemists synthesize a fungal compound that holds promise for treating brain cancervon 
An improved way to detach cells from culture surfacesvon 
Turning on an immune pathway in tumors could lead to their destructionvon 
New nanoparticles stimulate the immune system to attack ovarian tumorsvon Anne Trafton | MIT News am 31. Oktober 2025 um 10:00
Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.